Health District Releases Final Hepatitis C Report - 8 News NOW

Health District Releases Final Hepatitis C Report

Posted: Updated:

LAS VEGAS -- Nearly two years since the hepatitis C outbreak, the Southern Nevada Health District announced the investigation is complete.

From the very beginning, the investigation says the whole mess started from unsafe injection practices. What's important now is that every detail is outlined for the public to see.

"Even though we are done with our particular piece, the situation is not over. Protecting patient safety is the kind of an issue that will be a major issue for some time," said Brian Labus, Senior Epidemiologist with SNHD.

Read the SNHD's final report on the hepatitis C outbreak

Labus authored the report. To date, there are 106 possibly linked cases of hepatitis C. Nine cases are directly linked to the outbreak. It is the largest hepatitis C outbreak in the nation's history.

Metro completed its own investigation, which the District Attorney is still reviewing. At this point, it's unknown what criminal charges will fill be filed. Civil cases are still ongoing.

Labus hopes the report raises more awareness on both the physician side and the patient side. "It's getting people to understand the risk of these things – education. Getting patients involved in their own care, to ask questions and be comfortable saying, ‘What are you doing to keep me safe as a patient,'" he said.

A new campaign will be launched in Nevada in the beginning of 2010. Posters will be put up that stress the importance of using one needle, one syringe, only one time. The Centers for Disease Control received $2.5 million for the educational outreach.

Nevada and New York are the first two places where the printed campaign ads will be seen.

  • Paula's Health NotesLas Vegas Health NewsMore>>

  • Prostate frozen lumpectomy offers patients an alternative

    Prostate frozen lumpectomy offers patients an alternative

    Tuesday, July 29 2014 3:39 PM EDT2014-07-29 19:39:02 GMT
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
    More than 230,000 men will be diagnosed with prostate cancer this year according to the American cancer society. In most cases, surgical removal of the gland is considered the gold standard of treatment, but results of a new study suggest a new treatment might benefit some patients.More>>
  • New therapies for epilepsy

    New therapies for epilepsy

    Friday, July 25 2014 3:00 PM EDT2014-07-25 19:00:14 GMT
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
    pilepsy is a chronic neurological condition that affects more than 2.5 million Americans. Uncontrollable seizures plague these patients’ lives. Until now, the only treatments were drugs and major surgery, but new therapies are on the horizon.More>>
  • Study touts health care workers with less than bachelor's degree

    Study touts health care workers with less than bachelor's degree

    Thursday, July 24 2014 12:08 AM EDT2014-07-24 04:08:05 GMT
    Among Las Vegas workers with less than a bachelor’s degree only 3.5 percent hold jobs in the most common health care occupations, the lowest percentage among the nation’s 100 largest metropolitan areas, the Brookings Institution reported Wednesday night.More>>
    Among Las Vegas workers with less than a bachelor’s degree only 3.5 percent hold jobs in the most common health care occupations, the lowest percentage among the nation’s 100 largest metropolitan areas, the Brookings Institution reported Wednesday night.More>>
Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KLAS. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.